Sanggenon D | CAS No. 81422-93-7

Sanggenon D

Basic Information

View in Editor

CAS Number

81422-93-7

Molecular Formula

C40H36O12

Molecular Weight

708.71 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ketones

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Physical State

Powder

Melting Point

175-185 ºC

Density

1.512±0.06 g/cm3 (20 ºC 760 Torr),

Solubility

Insuluble (4.0E-6 g/L) (25 ºC),

SMILES

View in Editor

CC(=CCC12Oc3c(C2(O)Oc2c(C1=O)c(O)c(c(c2)O)C1C=C(C)CC(C1C(=O)c1ccc(cc1O)O)c1ccc(cc1O)O)ccc(c3)O)C

InChI

InChI=1S/C40H36O12/c1-18(2)10-11-39-38(49)35-32(52-40(39,50)27-9-6-22(43)16-31(27)51-39)17-30(46)34(37(35)48)26-13-19(3)12-25(23-7-4-20(41)14-28(23)44)33(26)36(47)24-8-5-21(42)15-29(24)45/h4-10,13-17,25-26,33,41-46,48,50H,11-12H2,1-3H3

InChIKey

SUOXGDJCEWTZIZ-UHFFFAOYSA-N

LogP

6.250200000000011

Topological Polar Surface Area

214.43999999999994 Å²

Hydrogen Bond Donor/Acceptor

8 / 12

Safety Information

View Safety Information

Storage Conditions

2-8℃

Synonyms & References

English

Sanggenon D
Sanggenone D
11H-Benzofuro[3,2-b][1]benzopyran-11-one,2- [6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)- 3-methyl-2-cyclohexen-1-yl]-5a,- 10a-dihydro-1,3,5a,8-tetrahydroxy-10a-(3- methyl-2-butenyl)-
2-[(1R,5S,6R)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-1,3,8,10a-tetrahydroxy-5a-(3-methylbut-2-enyl)-[1]benzofuro[3,2-b]chromen-11-one
I07-0320

MDL Number

MFCD12031639

FAQ

What regulatory guidelines apply to Sanggenon D (CAS: 81422-93-7)?

Sanggenon D (CAS: 81422-93-7) falls under the Classification, Labelling, and Packaging (CLP) regulation in the EU, which is part of the REACH regulations. In the USA, it is regulated by the EPA and FDA concerning its use in pharmaceutical and cosmetic products. The compound must comply with specific GHS classifications for transport and storage. Manufacturers should be aware of local and international regulations to ensure compliance.

Are there alternatives to Sanggenon D in synthesis?

There are several alternatives to Sanggenon D, including structurally similar compounds like sanguisorbin A and sanguisorbin B. Researchers often explore isomers and related analogs as substitutes. Common alternative reagents include various coupling agents and oxidizing agents that can be used in synthetic pathways to achieve similar functional groups.

What is the market or research trend for Sanggenon D?

The market for Sanggenon D is growing due to its potential anti-inflammatory and analgesic properties. Research trends are focused on understanding its mechanism of action and exploring its use in treating various inflammatory diseases. Market demand is also influenced by increasing interest in natural product derivatives for drug discovery. The research is advancing towards clinical trials and new formulations.

How should waste containing Sanggenon D be handled?

Waste containing Sanggenon D should be collected in appropriate non-leaking containers and stored in a secure area. The waste should be disposed of through incineration or professional waste disposal services that meet regulatory standards. Environmental protection guidelines must be followed to prevent contamination of soil and water. Proper labeling and documentation are essential for waste disposal to ensure compliance with environmental regulations.